Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Astellas, Kirin Tie Up for Fully Human Monoclonal Antibody
February 5, 2007
- GENERIC NEWS IN BRIEF
February 5, 2007
- Sale of Alimta to Be Limited to 400 Facilities for Now: Eli Lilly Japan
February 5, 2007
- Use of Generics Being Promotedby Spread of DPC System: Dr Chikamori
February 5, 2007
- METI to Solve Problems with Transfer Pricing Taxation System
February 5, 2007
- R&S NEWS IN BRIEF
February 5, 2007
- NPhA Leaders Committed to Solving Problem of Provisional Delivery
February 5, 2007
- AnGes MG Licenses Naglazyme from BioMarin
February 5, 2007
- BUSINESS NEWS IN BRIEF
February 5, 2007
- Ankhs Develops Drugs for Metastatic Cancer Using NR Ligands
January 29, 2007
- Retirement of Baby Boomers to Change Structure of Social Security System: Mr Kawasaki
January 29, 2007
- Kissei Announces Positive Results from PIII Trials of Silodosin in the US
January 29, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 29, 2007
- Enrollment Completed for PIII of Prasugrel: Daiichi Sankyo
January 29, 2007
- TOPIC an article
January 29, 2007
- Molecular Imaging Research Symposium 2007
January 29, 2007
- Generic Companies, Med. Device Makers to Become Targets of M&A: Mr Yamaguchi of Nikko Citigroup
January 29, 2007
- Japan Should Participate in More Multinational Trials: Dr Sato of PMDA
January 29, 2007
- MPC, Tanabe Discuss Merger -Merger to Give Birth to 6th Largest Japanese Company-
January 29, 2007
- Study Group for Early Approval of Drugs to Focus on Microdosing Studies
January 29, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…